Possible role of creatine concentrations in the brain in regulating appetite and weight

Brain Research

Volumn 1101, Issue 1, 2006, Pages 85-91

  Galbraith, Richard A ^a   Furukawa, Masaru ^a   Li, Muyao ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

guanidinopropionic acid; Appetite; Cobalt protoporphyrin; Creatine; Creatine transporter; Hypothalamus

Indexed keywords

CARRIER PROTEIN; COBALT DERIVATIVE; CREATINE; DRUG VEHICLE; GUANIDINOPROPIONIC ACID; MESSENGER RNA; PORPHYRIN COBALT; PROTEIN FOS; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; APPETITE; ARTICLE; BODY WEIGHT; BRAIN; BRAIN HOMOGENATE; BRAIN LEVEL; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DIFFERENTIAL DISPLAY; FEEDING; FOOD INTAKE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ANALYSIS; WEIGHT CONTROL; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; APPETITE REGULATION; BODY WEIGHT; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATINE; EATING; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENTRICULAR; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

ANIMALIA;

EID: 33745898264     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.032     Document Type: Article

References (35)

1. Bachmann C., Braissant O., Villard A.-M., Boulat O., and Henry H. Ammonia toxicity to the brain and creatine. Mol. Genet. Metab. 81 (2004) S52-S57
2. 3H]γ-Aminobutyric acid uptake into neuroglial cells of rat superior cervical sympathetic ganglia. J. Physiol. 293 (1979) 51-74
3. Braissant O., Henry H., Loup M., Eilers B., and Bachmann C. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Mol. Brain Res. 86 (2001) 193-201
4. Brustovetsky N., Brustovetsky T., and Dubinsky J.M. On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76 (2001) 425-434
5. Carling D. The AMP-activated protein kinase cascade-A unifying system for energy control. Trends Biochem. Sci. 29 (2004) 18-24
6. Carter A.J., and Mula R.E. Application and validation of an ionic exchange high performance liquid chromatographic method for measuring adenine nucleotides, creatine and creatine phosphate in mouse brain. J. Chromatogr. 527 (1990) 31-39
7. Defalco A.J., and Davies R.K. The synthesis of creatine by the brain of the intact rat. J. Neurochem. 7 (1961) 308-312
8. Dringen R., Verleysdonk S., Hamprecht B., Willker W., Leibfritz D., and Brand A. Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70 (1998) 835-840
9. Fitch C.D., and Chevil R. Inhibition of creatine and phosphocreatine accumulation in skeletal muscle and heart. Metabolism 29 (1980) 686-690
10. Galbraith R.A., and Kappas A. Regulation of food intake and body weight by cobalt porphyrins in animals. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7653-7657
11. Galbraith R.A., and Kappas A. Cobalt-protoporphyrin suppresses expression of genetic obesity in homozygous (fa/fa) Zucker rats. Pharmacology 41 (1990) 292-298
12. Galbraith R.A., and Kappas A. Cobalt protoporphyrin regulates body weight in beagle dogs: induction of weight loss in normal animals of stable adult weight. Pharmacology 43 (1991) 96-105
13. Galbraith R.A., and Kappas A. Intracerebroventricular administration of cobalt protoporphyrin elicits prolonged weight reduction in rats. Am. J. Physiol. 261 (1991) R1395-R1401
14. Galbraith R.A., and Kappas A. The effects of cobalt-protoporphyrin on food intake, body weight and metabolism in adult male rats. Am. J. Physiol. 261 (1991) R1388-R1394
15. Galbraith R.A., Kow L.M., Pfaff D., and Kappas A. Injection of cobalt protoporphyrin into the medial nuclei of the hypothalamus elicits weight loss. Am. J. Physiol. 263 (1992) R805-R812
16. Galbraith R.A., Hodgdon I., Grimm M.S., and Vizzard M.A. Prolonged retention of the anorectic cobalt protoporphyrin in the hypothalamus and the resulting expression of Fos. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 287 (2004) R465-R471
17. Holtzman D., Brown M., O'Gorman E., Allred E., and Wallimann T. Brain ATP metabolism in hypoxia resistant mice fed guanidinopropionic acid. Dev. Neurosci. 20 (1998) 469-477
18. Holtzman D., McFarland E., Moerland T., Koutcher J., Kushmerick M.J., and Neuringer L.J. Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine. Brain Res. 483 (1989) 68-77
19. 31P magnetic resonance study. J. Neurochem. 90 (2004) 1321-1330
20. Juhn M.S., and Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review. Clin. J. Sport Med. 8 (1998) 286-297
21. Karobath M., and Gunther S. Stimulation of benzodiazepine receptor binding by γ-aminobutyric acid. Proc. Natl. Acad. Sci. U. S A. 76 (1979) 1004-1006
22. + channels in the rat insulinoma cell line, CRI-GI. BMC Pharmacol. 4 (2004) 17-30
23. Li M., Vizzard M.A., Jaworski D.M., and Galbraith R.A. The weight loss elicited by cobalt protoporphyrin is related to diseased activity of nitric oxide synthase in the hypothalamus. J. App. Physiol. 100 (2006) 1983-1991
24. Mahanna D.A., Fitch C.D., and Fischer V.W. Effects of β-guanidinopropionic acid on murine skeletal muscle. Exp. Neurol. 68 (2004) 114-121
25. Moller A., and Hamprecht B. Creatine transport in cultured cells of rat and mouse brain. J. Neurochem. 52 (1989) 544-550
26. Ohtsuki S., Tachikawa M., Takanaga H., Shimizu H., Watanabe M., Hosoya K., and Terasaki T. The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J. Cereb. Blood Flow Metab. 22 (2002) 1327-1335
27. Rocic B., Breyer D., Granic M., and Milutinovic S. The effect of guanidino substances from uremic plasma on insulin binding to erythrocyte receptors in uremia. Horm. Metab. Res. 23 (1991) 490-494
28. Rocic B., Turk Z., Misur I., and Vucic M. Effect of creatine on glycation of albumin in vitro. Horm. Metab. Res. 27 (1995) 511-512
29. Roenneberg T., Nakamura H., and Woodland Hastings J. Creatine accelerates the circadian clock in a unicellular alga. Nature. 334 (1988) 432-434
30. Schmidt A., Marescau B., Boehm E.A., Renema W.K.J., Peco R., Das A., Steinfeld R., Chan S., Wallis J., Davidoff M., Ullrich K., Waldschutz R., Heerschap A., De Deyn P.P., Neubauer S., and Isbrandt D. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum. Mol. Genet. 13 (2004) 905-921
31. Schulze A. Creatine deficiency syndromes. Mol. Cell. Biochem. 244 (2003) 143-150
32. Speer O., Neukomm L.J., Murphy R.M., Zanolla E., Schlattner U., Henry H., Snow R.J., and Wallimann T. Creatine transporters: a reappraisal. Mol. Cell. Biochem. 256/257 (2004) 407-424
33. Tachikawa M., Fukaya M., Terasaki T., Ohtsuki S., and Watanabe M. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20 (2004) 144-160
34. Walzel B., Speer O., Zanolla E., Eriksson O., Bernardi P., and Wallimann T. Novel mitochondrial creatine transport activity. J. Biol. Chem. 40 (2002) 37503-37511
35. Wyss M., and Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?. Neuroscience 112 (2002) 243-260